Testing of micronized praziquantel and albendazole dosage forms against bothriocephalosis of cyprinids
The purpose of the research is to develop and test new dosage forms against bothriocephalosis of cyprinids.Materials and methods. The study was performed in the experimental therapy laboratory of the VNIIP – FSC VIEV, and on a cage fish farm of Cherepetsky Rybkhoz JSC (Suvorov, Tula Region). A formu...
Main Authors: | T. A. Vasilyeva, D. P. Skachkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Scientific Centre VIEV
2022-09-01
|
Series: | Российский паразитологический журнал |
Subjects: | |
Online Access: | https://vniigis.elpub.ru/jour/article/view/947 |
Similar Items
-
The efficacy of combined micronized Niclosamideand Albendazole-based dosage forms against bothriocephalosis of cyprinids
by: T. A. Vasilyeva, et al.
Published: (2023-01-01) -
Determination of the Minimum Effective Dosages of Praziquantel, Albendazole, and Mebendazole Against Clonorchis Sinensis Infection in Rats
by: Ping-Chin Fan, et al.
Published: (2005-10-01) -
Treatment of hepatic and pulmonary hydatidosis with albendazole and praziquantel
by: Popova G., et al.
Published: (2023-12-01) -
Resurgence of human bothriocephalosis (Diphyllobothrium latum) in the subalpine lake region
by: Renata BOUCHER-RODONI, et al.
Published: (2001-02-01) -
Severe adverse reaction induced by albendazole and praziquantel for cystic echinococcosis
by: Li Zhao, et al.
Published: (2023-01-01)